Company
Remixtx
Reprogramming RNA to transform patients’ lives.
Also known as Remix Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Watertown, MA, United States
- Founded
- 2020
- remixtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Remix Therapeutics is advancing a new class of therapeutics by modulating RNA processing with small molecules.
Funding snapshot
- Total raised
- $13.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $13.7M2023-12-22
Funding rounds
- Round, 2023
- $13.7M2023-12-22, SEC form D sold, 21 investors
Products
- Other
- REM-422
Loading relationship preview